Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention

被引:59
作者
Eccles, SA [1 ]
机构
[1] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England
关键词
motility; proteolysis; signalling; angiogenesis; invasion;
D O I
10.1387/ijdb.041820se
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Biological evolution is economical and successful fundamental processes are frequently recapitulated. There are remarkable similarities in the molecular mechanisms which enable tumour cells to invade into surrounding tissues and activated endothelial cells to generate new capillaries, which facilitate the growth and dissemination of cancer. Indeed these pathological processes are themselves based upon key vertebrate developmental processes, and in some cases parallel strategies used by microorganisms to colonise their hosts' tissues. The aim of this review is to explore these parallels in more detail and indicate possible pivotal points for therapeutic intervention. These novel approaches may ultimately optimise the selective targeting of processes involved in tumour invasion and angiogenesis, while sparing normal adult proliferating tissues. Strategies include inhibition of oncogenic pathways in tumour cells which not only stimulate tumour cell growth and invasion, but also initiate neoangiogenesis by upregulation of angiogenic cytokines. Secondly, downstream signalling pathways, transcriptional regulation and effectors common to both processes, and finally points of interaction/cross-talk between tumour cells and endothelial cells which are necessary to enable invasion and angiogenesis to proceed.
引用
收藏
页码:583 / 598
页数:16
相关论文
共 107 条
  • [1] RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion
    Abécassis, I
    Olofsson, B
    Schmid, M
    Zalcman, G
    Karniguian, A
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 291 (02) : 363 - 376
  • [2] Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma
    Apte, SM
    Fan, D
    Killion, JJ
    Fidler, IJ
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (03) : 897 - 908
  • [3] Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?
    Bauvois, B
    [J]. ONCOGENE, 2004, 23 (02) : 317 - 329
  • [4] Analysis of the role of chemokines in angiogenesis
    Bernardini, G
    Ribatti, D
    Spinetti, G
    Morbidelli, L
    Ziche, M
    Santoni, A
    Capogrossi, MC
    Napolitano, M
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 273 (1-2) : 83 - 101
  • [5] Met, metastasis, motility and more
    Birchmeier, C
    Birchmeier, W
    Gherardi, E
    Vande Woude, GF
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) : 915 - 925
  • [6] Combination of an src kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness
    Boyd, DD
    Wang, H
    Avila, H
    Parikh, NU
    Kessler, H
    Magdolen, V
    Gallick, GE
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1545 - 1555
  • [7] Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis
    Brader, S
    Eccles, SA
    [J]. TUMORI JOURNAL, 2004, 90 (01): : 2 - 8
  • [8] Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
    Brantley, DM
    Cheng, N
    Thompson, EJ
    Lin, Q
    Brekken, RA
    Thorpe, PE
    Muraoka, RS
    Cerretti, DP
    Pozzi, A
    Jackson, D
    Lin, C
    Chen, J
    [J]. ONCOGENE, 2002, 21 (46) : 7011 - 7026
  • [9] CANDIA P, 2003, P NATL ACAD SCI USA, V100, P12337
  • [10] Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
    Cavallaro, U
    Christofori, G
    [J]. NATURE REVIEWS CANCER, 2004, 4 (02) : 118 - 132